Even when available subject numbers are limited for recurrent genomic deletion CNVs with extremely low penetrance, it is possible to tune the disease gene/allele characterization strategy by targeting specific phenotypes, as demonstrated at the Smith Magenis Syndrome - MYO15 locus two decades ago [88]. The gene discussed is MYO15A; the disease is Smith-Magenis syndrome.